Intrinsic Value of S&P & Nasdaq Contact Us

Electromed, Inc. ELMD NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
81/100
5/7 Pass
SharesGrow Intrinsic Value
$21.38
-15.2%
Analyst Price Target
$38.00
+50.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Electromed, Inc. (ELMD) trades at a trailing P/E of 22.1, forward P/E of 22.9. Trailing earnings yield is 4.52%, forward earnings yield 4.36%. PEG 0.46 (Peter Lynch undervalued ≤1.0). Graham Number is $11.59.

Criteria proven by this page:

  • VALUE (74/100, Pass) — P/E is below market average (22.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.46); analyst target implies upside (+50.7%); earnings yield beats bond yields (4.52%).
  • PEG Ratio 0.46 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 4.52% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
  • Analyst consensus target $38.00 (+50.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
81/100
SG Score
View full scorecard →
VALUE
74/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
90/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — ELMD

Valuation Multiples
P/E (TTM)22.1
Forward P/E22.9
PEG Ratio0.46
Forward PEG0.82
P/B Ratio4.38
P/S Ratio2.91
EV/EBITDA14.7
Per Share Data
EPS (TTM)$1.09
Forward EPS (Est.)$1.10
Book Value / Share$5.49
Revenue / Share$8.33
FCF / Share$1.11
Yields & Fair Value
Earnings Yield4.52%
Forward Earnings Yield4.36%
Dividend Yield0.00%
Graham Number$11.59
SharesGrow IV$21.38 (-15.2%)
Analyst Target$38.00 (+50.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 14.2 0.13 1.92 1.37 -
2017 20.3 0.00 2.37 1.75 -
2018 24.3 -1.64 2.03 1.57 -
2019 22.2 5.10 1.71 1.40 -
2020 31.1 0.29 4.28 3.98 -
2021 40.9 -0.93 2.98 2.70 -
2022 35.4 -9.92 2.39 1.96 -
2023 28.6 0.77 2.41 1.89 -
2024 23.5 0.38 2.72 2.21 -
2025 24.3 0.49 4.24 2.86 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.27 $22.99M $2.21M 9.6%
2017 $0.26 $25.86M $2.23M 8.6%
2018 $0.22 $28.7M $1.9M 6.6%
2019 $0.23 $31.3M $1.97M 6.3%
2020 $0.47 $32.47M $4.16M 12.8%
2021 $0.27 $35.76M $2.36M 6.6%
2022 $0.26 $41.66M $2.31M 5.5%
2023 $0.36 $48.07M $3.17M 6.6%
2024 $0.58 $54.72M $5.15M 9.4%
2025 $0.86 $64M $7.54M 11.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.10 $1.09 – $1.11 $72.53M $72.43M – $72.61M 3
2027 $1.32 $1.30 – $1.33 $80.88M $80.44M – $81.3M 3
2028 $1.53 $1.52 – $1.54 $88.5M $87.98M – $89.17M 1
2029 $1.09 $1.08 – $1.10 $81.7M $81.22M – $82.31M 1
2030 $1.15 $1.14 – $1.16 $85.8M $85.3M – $86.45M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message